Preparing for the EU Health Technology Assessment: Key Insights from the Upcoming 2026 Webinar

By João L. Carapinha

January 5, 2026

The European Commission is organizing a webinar set for 15 January 2026 for health technology developers of medicinal products. The event provides guidance on EU Health Technology Assessment (HTA) Regulation prep, focused on Joint Clinical Assessments (JCAs) for certain medicinal products, with topics including dossier submissions, timelines, and EU HTA Coordination Group interactions. Practical sessions will cover regulatory processes, and registration stays open until mid-January 2026.

The EU HTA Regulation (EU) 2021/2282 is key, as endorsed by the European Parliament and Council, and it sets a voluntary framework that evolves to mandatory JCAs with goals including less duplication in HTA and boosting efficiency across 27 member states. See details on official EU Health Technology webpages.

Reference url

Recent Posts

Conditional Reimbursement in Chronic Pain Rehabilitation: Navigating Evidence Gaps and Patient Ac...

By João L. Carapinha

April 20, 2026

Healthcare stakeholders were informed in the Netherlands that Chronic Pain Rehabilitation through Interdisciplinary Medical Specialist Rehabilitation (IMSR) will be removed from the Dutch basic health insurance package for most patients. Under the new ruling by Zorginstituut Nederland, chronic pa...
Advancing Psychedelic Therapy Access for Treatment-Resistant Mental Illness

By João L. Carapinha

An Executive Order signed by President Donald J. Trump on April 18, 2026, will significantly advance psychedelic therapy access for serious mental illness. By removing regulatory and scheduling barriers, the order directs the FDA to issue Commissioner’s National Priority Vouchers for eligible psy...
Null Link Confirmed: Prenatal Acetaminophen Autism Risk Study in Denmark

By HEOR Staff Writer

April 17, 2026

A major nationwide Danish cohort study has found no link between maternal acetaminophen use during pregnancy and autism in children. The new evidence on prenatal acetaminophen autism risk should reassure clinicians and expectant mothers, as both population-wide and sibling-controlled analyses sho...